ARTICLE | Company News
Amgen, Immunomedics deal
February 5, 2001 8:00 AM UTC
IMMU received an $18 million upfront payment from partner AMGN under the companies’ December deal under which AMGN will develop and market in North America and Australia IMMU’s epratuzumab humanized m...